Capricor Therapeutics (CAPR) FCF Margin (QoQ) (2012 - 2024)

Capricor Therapeutics (CAPR) FCF Margin (QoQ) (2012 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Capricor Therapeutics 1.63 Bn 1.36 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2024 37,786.00
Sep 30, 2024 -20,424.00
Jun 30, 2024 -29,217.00
Mar 31, 2024 8,176.00
Dec 31, 2023 4,600.00
Sep 30, 2023 9,734.00
Jun 30, 2023 -37,319.00
Mar 31, 2023 92,066.00
Dec 31, 2022 -39,907.00
Jun 30, 2021 587,738.00
Mar 31, 2021 -110,494.00
Dec 31, 2020 1.14 Mn
Sep 30, 2020 -1.43 Mn
Jun 30, 2020 -360,387.00
Mar 31, 2020 14,770.00
Dec 31, 2019 35,865.00
Sep 30, 2019 -72,922.00
Jun 30, 2019 26,433.00
Mar 31, 2019 -11,797.00
Dec 31, 2018 84,694.00